Refile: BUZZ-Valneva rises on positive surprise from 2025 topline, cash burn outlook

Valneva SE

18/02/2025 08:20

(Adds missed comment attribution in 4th bullet point.)
    ** Stock in French vaccine producer Valneva  VLS.PA  rise
more than 6% as 2025 outlook positively surprises following
in-line 2024 revenue and cash figures
    ** Valneva eyes total revenues of between 180-190 million
euros ($188.19-198.65 million), with R&D spend between 90-100
million euros
    ** Van Lanschot Kempen flags "two positive surprises" in the
outlook, with topline guidance ahead of estimates and cash burn
to diminish by more than 50%, 
    ** It paints a picture of "an increasingly healthy base
business", Kempen says
    ** Portzamparc notes a cushy cash flow, leaving the biotech
company in a comfortable position to reach the next milestones
of its clinical developments
    ** Valneva is among the best performers on France's wider
SBF120 index  .SBF120 
 


($1 = 0.9565 euros)

 (Reporting by Jakob Van Calster)
 ((Jakob.vancalster@thomsonreuters.com))